このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Starpharma Holdings マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Cheryl Maley
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | less than a year |
CEOの所有権 | 0.03% |
経営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | 2.2yrs |
経営陣の近況
Recent updates
Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?
Dec 18We Think Some Shareholders May Hesitate To Increase Starpharma Holdings Limited's (ASX:SPL) CEO Compensation
Nov 22Here's Why Starpharma Holdings (ASX:SPL) Can Manage Its Debt Despite Losing Money
Mar 21We're Hopeful That Starpharma Holdings (ASX:SPL) Will Use Its Cash Wisely
Jan 26We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth
Jun 21Starpharma Holdings Limited (ASX:SPL): Is Breakeven Near?
May 16Here's Why We're Not At All Concerned With Starpharma Holdings' (ASX:SPL) Cash Burn Situation
Mar 02Is There An Opportunity With Starpharma Holdings Limited's (ASX:SPL) 27% Undervaluation?
Feb 10Starpharma Holdings Limited (ASX:SPL) Is Expected To Breakeven In The Near Future
Jan 20Did You Miss Starpharma Holdings' (ASX:SPL) Impressive 105% Share Price Gain?
Dec 28How Does Starpharma Holdings' (ASX:SPL) CEO Salary Compare to Peers?
Dec 07CEO(最高経営責任者
Cheryl Maley (55 yo)
less than a year
在職期間
Mrs. Cheryl Maley, B.Sc, DipEd, MBA, GAICD, serves as Chief Executive Officer, Managing Director and Director of Starpharma Holdings Limited since January 8. 2024. She served as Non-Executive Director of C...
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO, MD & Director | less than a year | データなし | 0.030% A$ 11.4k | |
Advisor to the Board | less than a year | AU$1.07m | 0.98% A$ 369.0k | |
Non-Executive Chairman | 10.5yrs | AU$134.00k | 0.35% A$ 132.0k | |
Non-Executive Director | 4.3yrs | AU$81.00k | 0.0039% A$ 1.5k | |
Non-Executive Director | 2.2yrs | AU$75.00k | 0.012% A$ 4.5k | |
Non-Executive Director | 1.3yrs | AU$27.01k | 0.017% A$ 6.5k | |
Non-Executive Director | 2.8yrs | AU$83.52k | 0.015% A$ 5.5k |
2.2yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: SPLの 取締役会 は 経験豊富 ではない ( 2.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。